Solutions for Pharma

Challenge

Need to develop objective measures of disease progression for a neurodegenerative condition in their clinical trials.

Solution

We implemented our digital measure platform to capture continuous movement data and cognitive function metrics through passive smartphone and wearablemonitoring.

Results

• Successfully validated novel digital endpoints of Quality of Life and Disease Progression
• Potential to reduce costs by 40% and patient-outcomes in HrQoL by 57%
• Patient compliance to 77%
• Generated rich real-world evidence data

Challenge

Need to close the loop between patients' visits using objective measures during care

Solution

We provided the digital measures, onboarding and analytics to patients to better understand their own health

Results

• Improved patient-caregiver communication
• Observed reduced time-with symptoms by clincians' drug-tuning
• L-Dopa 96% correlation with the digital measure of digital motor function
• Upcoming deployment in 5 hospitals

Challenge

improve the screening pathway of narcolepsy from obstructive sleep apnea (which is 60% misdiagnosed) using digital measures of daytime-movement and circadian response through heart-rate physiology.

Solution

We implemented our digital measure to relate daytime sleepiness and meal intake.

Results

• 0.85 AUC for the detection of daytime sleepiness
• Cost-benefit analysis shows 8x ROI on asset
• 0.83 average fix-rater ICC

Challenge

Sudden inflammation often leads to poor patient adherence and poor outcomes. We implemented a novel physiology and ADL-baseed digital biomarker platform to capture disease activity and patient engagement data.

Solution

Our platform provided continuous remote monitoring of symptoms and medication adherence, with real-time alerts for adverse events.

Results

• >6 digital biomarkers with high test-retest reliability
• Improved early detection of adverse events through passive sensing
• Enhanced patient engagement scores

Challenge

A pharmaceutical company needed to continue their clinical trials during the pandemic while ensuring patient safety and data quality.

Solution

We deployed our decentralized trial platform with remote monitoring capabilities and integrated ePRO collection.

Results

• Successfully transitioned 80% of trial activities to remote
• Maintained trial timeline without delays
• Reduced site visits by 60%
• Achieved 90% patient satisfaction rate